Systemic Antifungals Market Size, Share, By Drug Classes (Azoles, Echinocandins, Polyenes, and Others), Indication (Aspergillosis, Histoplasmosis, Gastrointestinal Candidiasis, Blastomycosis, Fungal Endocarditis, and Others), End-Users (Hospital & Specialty Clinics, Ambulatory Surgical Centers, Research Institute & Clinical Trial Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035

Rising Number of Patients with Fungal Infections Stimulate Market Growth

The market for systemic antifungals is growing as a direct result of an increase in fungal infections, particularly systemic ones. As more people get these serious fungal infections, there is a greater need for antifungal medications that work to treat the infection. Pharmaceutical companies are thus creating and distributing new systemic antifungal drugs to meet this growing demand.